Drug delivery: Thermo-responsive protein hydrogel

Bio-engineering researchers have created a biocompatible, protein-based hydrogel that could serve as a drug delivery system durable enough to survive in the body for more than two weeks while providing sustained medication release. The research advances an area of biochemistry that is also critical to tissue engineering and regenerative medicine. Protein hydrogels are more biocompatible than synthetic ones and do not require potentially toxic chemical crosslinkers.

Read more

Radiation may lower potential for side effects of CAR T therapy in non-hodgkin's lymphoma

Treating non-Hodgkin's lymphoma (NHL) patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side effects once it is administered.

Read more

Scanning the lens of the eye could predict type 2 diabetes and prediabetes

New research shows that specialist analysis of the lens in the eye can predict patients with type 2 diabetes and impaired glucose tolerance (IGT) (also known as prediabetes, a condition that often leads to full blown of type 2 diabetes).

Read more